I agree that this site is using cookies. You can find further informations here.
X
Vergote, Ignace
755  results:
Search for persons X
?
1

Primary results of the AGO-Zervix-1 Study: A prospective, r..:

Gass, Paul ; Thiel, Falk C. ; Häberle, Lothar...
Gynecologic Oncology.  183 (2024)  - p. 25-32 , 2024
Link: https://doi.org/10.1016/..
 
?
2

TIM3 Checkpoint Inhibition Fails to Prolong Survival in Ova..:

Berckmans, Yani ; Vankerckhoven, Ann ; Caro, Aarushi Audhut...
Cancers.  16 (2024)  6 - p. 1147 , 2024
Link: https://doi.org/10.3390/..
 
?
3

Tumor Treating Fields (TTFields) induce homologous recombin..:

Berckmans, Yani ; Ene, Hila M. ; Ben-Meir, Kerem...
Frontiers in Oncology.  14 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
4

Correction: Dynamics of clonal hematopoiesis under DNA-dama..:

Arends, Christopher Maximilian ; Kopp, Klara ; Hablesreiter, Raphael...
Leukemia.  38 (2024)  6 - p. 1440-1440 , 2024
Link: https://doi.org/10.1038/..
 
?
5

Predictors of long-term progression-free survival in patien..:

Graybill, Whitney S ; Pardo Búrdalo, Beatriz ; O'Malley, David M...
International Journal of Gynecologic Cancer.  34 (2024)  7 - p. 1041-1050 , 2024
Link: https://doi.org/10.1136/..
 
?
6

Clinical evaluation of a low-coverage whole-genome test for..:

Boidot, Romain ; Blum, Michael G.B. ; Wissler, Marie-Pierre...
European Journal of Cancer.  202 (2024)  - p. 113978 , 2024
Link: https://doi.org/10.1016/..
 
?
7

Gene expression markers in peripheral blood and outcome in ..:

Obermayr, Eva ; Mohr, Thomas ; Schuster, Eva...
International Journal of Cancer.  , 2024
Link: https://doi.org/10.1002/..
 
?
8

Progression-free survival and safety at 3.5 years of follow..:

González-Martín, Antonio ; Pothuri, Bhavana ; Vergote, Ignace...
Future Oncology.  , 2024
Link: https://doi.org/10.2217/..
 
?
9

ENGOT-EN20/GOG-3083/XPORT-EC-042 – A phase III, randomized,..:

Vergote, Ignace ; Perez Fidalgo, Alejandro ; Valabrega, Giorgio...
International Journal of Gynecologic Cancer.  , 2024
Link: https://doi.org/10.1136/..
 
?
10

Dynamics of clonal hematopoiesis under DNA-damaging treatme..:

Arends, Christopher Maximilian ; Kopp, Klara ; Hablesreiter, Raphael...
Leukemia.  38 (2024)  6 - p. 1378-1389 , 2024
Link: https://doi.org/10.1038/..
 
?
11

Long-term follow-up of efficacy and safety of selinexor mai..:

Makker, Vicky ; Perez-Fidalgo, Jose Alejandro ; Valabrega, Giorgio...
Gynecologic Oncology.  185 (2024)  - p. 202-211 , 2024
Link: https://doi.org/10.1016/..
 
?
12

Phase 1b study of mirvetuximab soravtansine, a folate recep..:

Richardson, Debra L. ; Moore, Kathleen N. ; Vergote, Ignace...
Gynecologic Oncology.  185 (2024)  - p. 186-193 , 2024
Link: https://doi.org/10.1016/..
 
?
13

Loss of copy numbers of retrotransposons (HERVK) on chromos..:

Fromhage, Gesa ; Obermayr, Eva ; Bednarz‐Knoll, Natalia...
International Journal of Cancer.  155 (2024)  5 - p. 934-945 , 2024
Link: https://doi.org/10.1002/..
 
?
14

Development of the NOGGO GIS v1 Assay, a Comprehensive Hybr..:

Willing, Eva-Maria ; Vollbrecht, Claudia ; Vössing, Christine...
Cancers.  15 (2023)  13 - p. 3445 , 2023
Link: https://doi.org/10.3390/..
 
?
15

Tisotumab vedotin in recurrent or metastatic cervical cance:

Bogani, Giorgio ; Coleman, Robert L. ; Vergote, Ignace...
Current Problems in Cancer.  47 (2023)  3 - p. 100952 , 2023
Link: https://doi.org/10.1016/..
 
1-15